Cargando…
Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype
Quantification of cell-free DNA (cfDNA) in circulating blood derived from a transplanted organ is a powerful approach to monitoring post-transplant injury. Genome transplant dynamics (GTD) quantifies donor-derived cfDNA (dd-cfDNA) by taking advantage of single-nucleotide polymorphisms (SNPs) distrib...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542400/ https://www.ncbi.nlm.nih.gov/pubmed/28771616 http://dx.doi.org/10.1371/journal.pcbi.1005629 |
_version_ | 1783254985077686272 |
---|---|
author | Sharon, Eilon Shi, Hao Kharbanda, Sandhya Koh, Winston Martin, Lance R. Khush, Kiran K. Valantine, Hannah Pritchard, Jonathan K. De Vlaminck, Iwijn |
author_facet | Sharon, Eilon Shi, Hao Kharbanda, Sandhya Koh, Winston Martin, Lance R. Khush, Kiran K. Valantine, Hannah Pritchard, Jonathan K. De Vlaminck, Iwijn |
author_sort | Sharon, Eilon |
collection | PubMed |
description | Quantification of cell-free DNA (cfDNA) in circulating blood derived from a transplanted organ is a powerful approach to monitoring post-transplant injury. Genome transplant dynamics (GTD) quantifies donor-derived cfDNA (dd-cfDNA) by taking advantage of single-nucleotide polymorphisms (SNPs) distributed across the genome to discriminate donor and recipient DNA molecules. In its current implementation, GTD requires genotyping of both the transplant recipient and donor. However, in practice, donor genotype information is often unavailable. Here, we address this issue by developing an algorithm that estimates dd-cfDNA levels in the absence of a donor genotype. Our algorithm predicts heart and lung allograft rejection with an accuracy that is similar to conventional GTD. We furthermore refined the algorithm to handle closely related recipients and donors, a scenario that is common in bone marrow and kidney transplantation. We show that it is possible to estimate dd-cfDNA in bone marrow transplant patients that are unrelated or that are siblings of the donors, using a hidden Markov model (HMM) of identity-by-descent (IBD) states along the genome. Last, we demonstrate that comparing dd-cfDNA to the proportion of donor DNA in white blood cells can differentiate between relapse and the onset of graft-versus-host disease (GVHD). These methods alleviate some of the barriers to the implementation of GTD, which will further widen its clinical application. |
format | Online Article Text |
id | pubmed-5542400 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-55424002017-08-12 Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype Sharon, Eilon Shi, Hao Kharbanda, Sandhya Koh, Winston Martin, Lance R. Khush, Kiran K. Valantine, Hannah Pritchard, Jonathan K. De Vlaminck, Iwijn PLoS Comput Biol Research Article Quantification of cell-free DNA (cfDNA) in circulating blood derived from a transplanted organ is a powerful approach to monitoring post-transplant injury. Genome transplant dynamics (GTD) quantifies donor-derived cfDNA (dd-cfDNA) by taking advantage of single-nucleotide polymorphisms (SNPs) distributed across the genome to discriminate donor and recipient DNA molecules. In its current implementation, GTD requires genotyping of both the transplant recipient and donor. However, in practice, donor genotype information is often unavailable. Here, we address this issue by developing an algorithm that estimates dd-cfDNA levels in the absence of a donor genotype. Our algorithm predicts heart and lung allograft rejection with an accuracy that is similar to conventional GTD. We furthermore refined the algorithm to handle closely related recipients and donors, a scenario that is common in bone marrow and kidney transplantation. We show that it is possible to estimate dd-cfDNA in bone marrow transplant patients that are unrelated or that are siblings of the donors, using a hidden Markov model (HMM) of identity-by-descent (IBD) states along the genome. Last, we demonstrate that comparing dd-cfDNA to the proportion of donor DNA in white blood cells can differentiate between relapse and the onset of graft-versus-host disease (GVHD). These methods alleviate some of the barriers to the implementation of GTD, which will further widen its clinical application. Public Library of Science 2017-08-03 /pmc/articles/PMC5542400/ /pubmed/28771616 http://dx.doi.org/10.1371/journal.pcbi.1005629 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication. |
spellingShingle | Research Article Sharon, Eilon Shi, Hao Kharbanda, Sandhya Koh, Winston Martin, Lance R. Khush, Kiran K. Valantine, Hannah Pritchard, Jonathan K. De Vlaminck, Iwijn Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype |
title | Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype |
title_full | Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype |
title_fullStr | Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype |
title_full_unstemmed | Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype |
title_short | Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype |
title_sort | quantification of transplant-derived circulating cell-free dna in absence of a donor genotype |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542400/ https://www.ncbi.nlm.nih.gov/pubmed/28771616 http://dx.doi.org/10.1371/journal.pcbi.1005629 |
work_keys_str_mv | AT sharoneilon quantificationoftransplantderivedcirculatingcellfreednainabsenceofadonorgenotype AT shihao quantificationoftransplantderivedcirculatingcellfreednainabsenceofadonorgenotype AT kharbandasandhya quantificationoftransplantderivedcirculatingcellfreednainabsenceofadonorgenotype AT kohwinston quantificationoftransplantderivedcirculatingcellfreednainabsenceofadonorgenotype AT martinlancer quantificationoftransplantderivedcirculatingcellfreednainabsenceofadonorgenotype AT khushkirank quantificationoftransplantderivedcirculatingcellfreednainabsenceofadonorgenotype AT valantinehannah quantificationoftransplantderivedcirculatingcellfreednainabsenceofadonorgenotype AT pritchardjonathank quantificationoftransplantderivedcirculatingcellfreednainabsenceofadonorgenotype AT devlaminckiwijn quantificationoftransplantderivedcirculatingcellfreednainabsenceofadonorgenotype |